Latest News

Amid recent volatility in the U.S. markets, with major indices like the Dow Jones and S&P 500 experiencing significant fluctuations due to geopolitical tensions and economic policy shifts, investors are keenly observing opportunities that may arise from these movements. In such an environment, identifying stocks that are potentially undervalued based on intrinsic value estimates can offer a strategic advantage, as they might provide growth potential when market conditions stabilize.

Major stock indexes saw a significant rebound recently, with the Dow Jones adding 450 points after President Trump ruled out the use of force in Greenland. Amidst this backdrop of market volatility and geopolitical tensions, investors are exploring opportunities beyond traditional stocks. Penny stocks, often representing smaller or newer companies, continue to attract attention for their potential value and growth prospects. In this article, we explore three penny stocks that showcase...

St George Mining recently reported strong drilling results at its 100%-owned Araxá Rare Earths and Niobium Project in Brazil, confirming thick, high-grade mineralisation extending beyond the current resource boundaries. The emerging high-grade zone northwest of the existing resource, which could be mined independently, adds potential flexibility to future development options at Araxá. With this new high-grade zone in focus, we’ll examine how the Araxá results reshape St George Mining’s...

UFP Industries recently reported that unit sales have fallen over the past two years, with earnings per share dropping faster than revenue and returns on capital slipping, pointing to past profit pools becoming harder to sustain. This combination of weaker volumes, compressed earnings, and declining capital efficiency raises fresh questions about how durable the company’s profit engine may be. Next, we’ll examine how the ongoing slide in earnings per share shapes UFP Industries’ investment...

Corvus Pharmaceuticals recently reported positive results from cohort 4 of its randomized, blinded, placebo-controlled Phase 1 trial of oral soquelitinib in moderate to severe atopic dermatitis, and confirmed plans to start a Phase 2 study in the first quarter of 2026. The cohort 4 data are particularly interesting because they show clinical activity in patients who had previously failed systemic treatments, including dupilumab and JAK inhibitors, while maintaining a favorable safety profile...

Aurelia Metals has released its December 2025 quarterly update and Q2 2026 results, reporting strong multi-metal production, solid cash generation, and reaffirmed FY26 guidance alongside ongoing ramp-up at the Federation Mine and expansions at Great Cobar and Peak. An interesting angle for investors is how the ahead-of-plan Federation ramp-up and promising Nymagee and Federation drilling results may underpin future capacity growth and resource potential. We’ll now explore how Aurelia Metals’...

In January 2026, Blue Moon Group Holdings Limited announced earnings guidance indicating it expects at least a 50% reduction in its loss attributable to equity holders for 2025 compared with the approximately HK$749.30 million loss recorded for 2024. The company attributes this anticipated improvement to tighter cost optimisation, streamlined operations and continued investment in new product promotion and channel expansion, particularly for concentrated liquid laundry detergents. Next, we...

Disc Medicine recently faced a two-week postponement of the U.S. FDA’s review of its rare disease candidate bitopertin, as regulators raised questions about efficacy endpoints, data integrity, and potential abuse risk. At the same time, the company appointed industry veteran Lisa Amaya Price as Chief Human Resources Officer, signaling an effort to strengthen its organizational backbone as it prepares for possible commercialization. Next, we’ll examine how the FDA’s temporary review delay for...

Lonking Holdings Limited recently issued earnings guidance for the year ended December 31, 2025, expecting net profit of about RMB 1,250 million to RMB 1,330 million, implying a significant increase of 23% to 31% versus the prior year. The company attributes this stronger profitability to growth in domestic and export sales, a larger contribution from high-value-added new products, and successful efforts to improve quality, control costs, and lift overall gross profit margins. Next, we will...

First Capital REIT announced a 2.5% increase in its annualized cash distribution to $0.912 per unit, with the January 2026 payout of $0.076 per unit scheduled for February 16, 2026 to unitholders of record as of January 30, 2026. This distribution increase highlights management’s confidence in the REIT’s cash flow profile and may appeal to income-focused investors in Canada’s retail real estate sector. We’ll now examine how this 2.5% distribution increase shapes First Capital REIT’s...

Reverse split reshapes Ozop Energy Solutions share structure Ozop Energy Solutions (OZSC) is carrying out a 1 for 5,000 reverse stock split effective January 21, 2026. This move sharply consolidates its share count and changes the trading price per share. This type of corporate action does not alter the company’s reported revenue of US$0.32 million or its loss of US$6.95 million, but it can influence liquidity, trading behavior, and how different investors view the stock. See our latest...

Earlier in January 2026, Citi and JPMorgan published upbeat research on China’s life insurance industry, highlighting wealth reallocation, stable margins and stronger fundamentals across Asian insurers. Both banks singled out China Life Insurance as a preferred industry leader, suggesting it could be a key beneficiary of any sector-wide re-rating and regulatory-driven divergence. Next, we’ll examine how this supportive analyst sentiment, particularly around wealth reallocation into insurance...

Omega Healthcare Investors (NYSE:OHI) is showing a strong technical breakout pattern, pointing to renewed investor interest in the healthcare REIT space. The breakout aligns with a confirmed uptrend and a solid technical setup that traders may use as a rule-based entry signal. With shares last closing at $45.04, the move is drawing fresh attention from investors watching healthcare focused real estate names. For context, Omega Healthcare Investors has delivered a 28.1% return over the past...

If you are wondering whether Abbott Laboratories at around US$121 a share is offering fair value or a potential mispricing, you are in the right place. The stock is modestly positive over 1 year with a 5.7% return, but has seen shorter term pullbacks with a 2.5% decline over 7 days and a 3.4% decline over 30 days, while the 3 and 5 year figures sit at 14.2% and 15.7% respectively. Recent headlines around Abbott Laboratories have focused on its position in medical devices and diagnostics, as...

In January 2026, Vallourec announced it had secured a major contract with Shell to supply OCTG products and comprehensive offshore and onshore services for the Orca (formerly Gato do Mato) offshore development, covering 10 planned wells and an estimated 12,000 to 15,000 tons of pipes ahead of expected drilling in April 2027. The contract underscores Vallourec’s role as a key supplier of seamless pipes, VAM premium connections, and integrated engineering support across a wide range of...

If you are wondering whether Origin Bancorp's current share price reflects solid value or hidden risk, it helps to start by lining up the recent performance with what you are actually paying for the business. The stock last closed at US$39.70, with returns of 1.1% over 7 days, 2.1% over 30 days, 5.5% year to date, 13.1% over 1 year, 8.7% over 3 years, and 47.1% over 5 years. This gives useful context before comparing the price to fundamentals. Recent coverage has focused on Origin Bancorp's...

If you are wondering whether Ivanhoe Mines is attractively priced right now, it helps to first line up the recent share performance with what the current valuation is actually implying. The stock most recently closed at $16.08, with a 10.6% gain over the last 30 days sitting alongside a small 0.2% return year to date and a 2.5% decline over the past year. Taken together, this gives a mixed picture of how the market is currently treating the shares. Over a longer stretch, investors have seen...

If you are trying to figure out whether Bilibili is attractively priced today, the key question is whether the recent share price reflects its underlying fundamentals or leaves room for value. Bilibili last closed at US$30.27, with a 7 day return of 3.6% decline, a 30 day return of 22.2% and a 1 year return of 77.5%, which sits alongside a 3 year return of 18.1% and a 5 year return of 76.0% decline. These moves sit against ongoing investor focus on Chinese tech and media names, where risk...

Gap Inc. (NYSE:GAP) has created a new Chief Entertainment Officer role and appointed Pam Kaufman. The company is launching a "Fashiontainment" approach that connects its brands more closely with entertainment and media. Gap is establishing an entertainment focused hub in Los Angeles to anchor content, partnerships, and collaborations. The first major licensing effort under this push is the Artist Series, featuring Robert Indiana's LOVE artwork. Gap Inc. (NYSE:GAP) is known for its core...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

Rivulet Entertainment (OTCPK:RIVF) opened 2026 with a quiet top line and a deeper loss, reporting Q1 total revenue of US$0 and a net loss of US$0.97 million, which translated to basic EPS of US$0.01. Over recent quarters the company has seen revenue move between US$0 and US$10 million, while quarterly basic EPS ranged from about US$0.00 to US$0.03 in losses. This sets a backdrop where margin pressure rather than sales growth is front and center for investors parsing this update. See our full...

When close to half the companies in Romania have price-to-earnings ratios (or "P/E's") below 15x, you may consider...

Daimler Truck Holding (XTRA:DTG) has been in focus after reshaping Fuso’s European sales network through a new partnership with Emil Frey Group, along with the regional rollout of its electric eCanter truck in the UAE. See our latest analysis for Daimler Truck Holding. Those Fuso and eCanter updates come as Daimler Truck Holding’s share price sits at €40.00, with recent momentum mixed, a 30 day share price return of 6.87% and a three month share price return of 13.93%, while the one year...

Scientific Games recently announced it has been selected as a digital partner to the Lotteries Entertainment Innovation Alliance, a two-year collaboration that includes FDJ United in France, to supply digital game projects and localized content. This partnership highlights how FDJ United and other alliance members are leaning on external digital expertise to broaden their reach and improve operational efficiency in online lottery offerings. We’ll now examine how this new digital game...